Search results for "Highlights"
HCV medications decreased liver disease among those using injection drugs
A Baltimore-based study found that half of participants with chronic hepatitis C virus (HCV) and a history of injection drug use at baseline were free of the virus by 2019, with associated reductions in their risk of cirrhosis and mortality.
https://gastroenterology.acponline.org/archives/2022/07/22/2.htm
22 Jul 2022
Cost may be common factor in drug nonadherence among patients with chronic liver disease
About 25% of 3,237 respondents with chronic liver disease in the National Health Interview Survey from 2014 through 2018 reported not taking their medications as prescribed due to cost.
https://gastroenterology.acponline.org/archives/2021/06/25/4.htm
25 Jun 2021
Poor oral health associated with hospitalizations in outpatients with cirrhosis
Over three months, patients with cirrhosis who were hospitalized for nonelective reasons were more likely than those who were not to be decompensated, with higher rates of minimal hepatic encephalopathy plus frailty and history of periodontitis.
https://gastroenterology.acponline.org/archives/2022/11/18/2.htm
18 Nov 2022
Pandemic may have led to later presentation of colorectal, breast cancers
A single-center study in California found that more patients presented with stage I disease and fewer presented with stage IV disease in 2019 versus 2020, but the changes were statistically significant only for breast cancer.
https://gastroenterology.acponline.org/archives/2022/02/25/3.htm
25 Feb 2022
Pickle juice reduced cramp severity in patients with cirrhosis
A small trial randomized 82 patients with cirrhosis and frequent muscle cramps to drink either a sip of pickle brine or tap water when they developed cramps and found a significant reduction in cramp severity scores in the former group.
https://gastroenterology.acponline.org/archives/2022/04/22/3.htm
22 Apr 2022
Review finds upadacitinib most effective for moderate to severe ulcerative colitis remission
The systematic review and meta-analysis of biologic and small-molecule drugs for patients with moderate to severe ulcerative colitis also found that upadacitinib ranked highest for adverse events, whereas vedolizumab had the lowest rate of adverse events and serious adverse events.
https://gastroenterology.acponline.org/archives/2021/12/17/2.htm
17 Dec 2021
Spotlight on Helicobacter pylori treatment
A review found that susceptibility-guided therapy may be the superior first-line treatment for H. pylori infection in areas with high antibiotic resistance, while a study of trial participants with 26.5 years of follow-up showed that H. pylori eradication may provide long-term protection against gastric cancer.
https://gastroenterology.acponline.org/archives/2022/04/22/5.htm
22 Apr 2022
AGA releases new guidance on coagulation disorders in patients with cirrhosis
A clinical practice guideline from the American Gastroenterological Association (AGA) suggested against extensive preprocedural testing in patients with stable cirrhosis who are undergoing routine GI procedures, among other recommendations.
https://gastroenterology.acponline.org/archives/2021/11/19/3.htm
19 Nov 2021
U.S. sees decrease in HCC disease burden
Incidence of hepatocellular carcinoma (HCC) decreased sharply by 2.3% annually after 2011, while incidence-based mortality saw a 3.2% annual decrease after 2013, according to a study based on national data.
https://gastroenterology.acponline.org/archives/2022/02/25/2.htm
25 Feb 2022
New best practice advice tackles pain in disorders of gut-brain interaction
An expert review from the American Gastroenterological Association cautioned against using opioids to treat pain from irritable bowel syndrome, functional dyspepsia, or centrally mediated abdominal pain syndrome, among other advice.
https://gastroenterology.acponline.org/archives/2021/07/23/2.htm
23 Jul 2021